Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects

Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects

Item
http://www.wikidata.org/entity/Q57271781
Population pharmacokinetics of rituximab in patients with diffuse large B-cell lymphoma and association with clinical outcomeInhibition of neutrophil collagenase/MMP-8 and gelatinase B/MMP-9 and protection against endotoxin shock.Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats.Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.Stability of stock and diluted rituximab.Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab.Quantification of an intact monoclonal antibody, rituximab, by (RP)HPLC/DAD in compliance with ICH guidelines.
P2860

Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects

Item
http://www.wikidata.org/entity/Q57271781
description
scientific article published on 11 June 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2010
@uk
name
Validation of an ELISA for the ...... cs in clinical trials subjects
@en
Validation of an ELISA for the ...... cs in clinical trials subjects
@nl
type
label
Validation of an ELISA for the ...... cs in clinical trials subjects
@en
Validation of an ELISA for the ...... cs in clinical trials subjects
@nl
prefLabel
Validation of an ELISA for the ...... cs in clinical trials subjects
@en
Validation of an ELISA for the ...... cs in clinical trials subjects
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Validation of an ELISA for the ...... cs in clinical trials subjects
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698